Table 1 Baseline clinical characteristics
DES (n = 51) | DCB (n = 24) | p-value | |
|---|---|---|---|
Age (year) | 64.3 ± 10.9 | 64.8 ± 11.3 | 0.85 |
Men, n (%) | 41 (80.4) | 17 (70.8) | 0.36 |
Current smoker, n (%) | 16 (31.4) | 6 (25) | 0.57 |
Hypertension, n (%) | 34 (66.7) | 14 (58.3) | 0.48 |
Diabetes, n (%) | 23 (45.1) | 9 (37.5) | 0.54 |
Prior MI, n (%) | 16 (31.4) | 6 (25) | 0.57 |
Diagnosis at the index PCI | 0.12 | ||
SA/UA, n (%) | 38 (74.5) | 22 (91.7) | |
NSTEMI/STEMI, n (%) | 13 (25.5) | 2 (8.3) | |
Laboratory findings | |||
Total cholesterol (mg/dL) | 151.5 ± 49.3 | 151.8 ± 35.0 | 0.98 |
LDL-C (mg/dL) | 81.7 ± 38.1 | 92.9 ± 35.1 | 0.09 |
HDL-C (mg/dL) | 41.6 ± 12.4 | 41.4 ± 8.8 | 0.77 |
Triglyceride (mg/dL) | 151.7 ± 83.8 | 134.1 ± 89.8 | 0.21 |
Glucose (mg/dL) | 126.1 ± 37.3 | 127.4 ± 55.2 | 0.68 |
Creatinine (mg/dL) | 1.13 ± 0.63 | 1.02 ± 0.36 | 0.44 |
hsCRP (mg/L) | 7.69 ± 24.14 | 7.26 ± 17.98 | 0.87 |
LVEF, n (%) | 52.6 ± 10.4 | 53.8 ± 10.7 | 0.41 |